Alison Dziarmaga, Vice President and U.S. Breast Cancer Franchise Head at AstraZeneca, ...

If the Phase III trials of the oral GLP-1RA are successful, AstraZeneca is set to join a fast-growing market.

AstraZeneca is emerging as a potential new contender in the booming obesity treatment market after its experimental ...

The LinkedIn activities of AstraZeneca employees have yet again landed the drugmaker in hot water, with the U.K. marketing ...

AstraZeneca (LSE:AZN) is advancing its oral GLP-1 candidate elecoglipron into Phase 3 trials after positive Phase 2b results.

A new pill developed by the British pharmaceutical firm AstraZeneca appears to help people lose a similar amount of weight as ...

Pharmaceutical companies AstraZeneca and Eli Lilly & Co. are planning to locate major manufacturing facilities in Albemarle and Goochland counties respectively, a state official has confirmed. Last ...

Enhertu is an antibody-drug conjugate developed for the treatment of certain HER2-expressing cancers and is already approved ...

AstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This ...

BMS ($15.2B), and Pfizer ($10.5B) anchored early-2026 China partnering, reflecting a structural shift from ~5% of licensing four years ago to a majority today. China dealmaking expanded from $51.9B ...

Trump administration readies pre-blame for World Cup Ebola outbreaks; The end of pharma advertising nears?; AstraZeneca works ...